amyotrophic lateral sclerosis
-
ALS anxiety, amyotrophic lateral sclerosis, Anxiety, Beck Depression Inventory, depression, frontotemporal dementia, motor neuron disease, Neurodegenerative Diseases, Psychiatry, psychological distress, STAI, state anxiety, trait anxietyALS Anxiety: 18% State, 14% Trait in 433 Patients
In 433 non-demented amyotrophic lateral sclerosis (ALS) patients, clinically significant anxiety was…
-
AB10015, ALS, ALS survival, ALSFRS-R, amyotrophic lateral sclerosis, Drugs, ENCALS, masitinib, mast cells, microglia, motor neuron disease, Neurodegenerative Diseases, neuroscience, riluzole, tyrosine kinase inhibitorMasitinib for ALS: AB10015 Reports 42.3% 5-Year Survival
A 2026 AB10015 post-hoc preprint reported 42.3% 5-year survival from amyotrophic lateral…
-
ALS biomarkers, ALSFRS-R, amyotrophic lateral sclerosis, cerebrospinal fluid, complement proteins, CSF proteomics, machine learning biomarkers, mass spectrometry, neurodegeneration, Neurodegenerative Diseases, neurofilament light, neuroscienceALS CSF Proteomics Found 399 Candidate Proteins and a 5-Protein Panel
A 2026 cerebrospinal-fluid proteomics preprint involving 87 amyotrophic lateral sclerosis (ALS) patients,…
-
ALS, ALSFRS, ALSFRS-R, amyotrophic lateral sclerosis, clinical trial endpoints, functional decline, motor neuron disease, Neurodegenerative Diseases, neuroscience, ordinal outcome scales, PRO-ACT, Psychiatry, Psychology, Shannon entropy, Simpson’s paradoxALS Entropy Analysis Finds 5-Month Signal Hidden by ALSFRS Scores
A 2026 PRO-ACT analysis of amyotrophic lateral sclerosis (ALS) trial data found…
